TOP TIERMARKET NEWSWIRE
News & sentiment

MAZE THERAPEUTICS IN (MAZE) — News & AI sentiment

MAZE THERAPEUTICS IN (MAZE) news roundup. 2 stories in the past week, 6 over 30 days. Average 30-day sentiment is 56.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 12 sales totalling $4.9M — net selling of $4.9M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 52/100
30d stories
6
avg sentiment 56.5/100
Insider net (90d)
$4.9M
0 buys · 12 sells
Congress (90d)
0
0 buys · 0 sells

MAZE news in the last 24 hours, 7 days, 30 days and 90 days

How much MAZE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMAZE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days252/100MAZE headlines →
Last 30 days656.5/100MAZE headlines →
Last 90 days2753.5/100MAZE headlines →

Latest stories on MAZE

6d ago
6d ago
Oct 19
Oct 19
Maze Therapeutics, Inc. (MAZE) files 8-K
SEC 8-K50 · neutralgeneral
Oct 16
Oct 13
Oct 6
Oct 6
Oct 5
Sep 23
Why is Maze Therapeutics stock climbing today?
Investing.com Markets50 · neutralgeneral
Sep 23
Sep 23
Sep 22
Sep 22
Sep 11
Sep 11
Sep 10
Sep 2
Sep 2
Aug 26
Aug 17
Maze Therapeutics, Inc. (MAZE) files 8-K
SEC 8-K50 · neutralgeneral
Aug 17
Aug 13
Maze Therapeutics, Inc. (MAZE) files 8-K
SEC 8-K50 · neutralgeneral
Aug 11
Aug 11
Open MAZE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →